Evidence map›Paper›PMID 36405291›Full record

ReviewWorld journal of clinical cases2022

Overlap of diabetic ketoacidosis and hyperosmolar hyperglycemic state.

Esraa Mamdouh Hassan, Hisham Mushtaq, Esraa Elaraby Mahmoud, Sherley Chhibber, Shoaib Saleem, Ahmed Issa, Jain Nitesh, Abbas B Jama, Anwar Khedr, Sydney Boike and 4 more

Open access · diamondAbstract readReview
In one paragraph

Review in World journal of clinical cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 5 countries.

Esraa Mamdouh HassanCritical Care Medicine, Mayo Clinic Health System, Mankato, MN 56001, United States.
Hisham MushtaqMedicine, St. Vincent's Medical Center, Bridgeport, CT 06606, United States.
Esraa Elaraby MahmoudMedicine, College of Medicine, University of Sharjah, Sharjah 27272, United Arab Emirates.
Sherley ChhibberMedicine, Mercy Catholic Medical Center, Darby, PA 19025, United States.
Shoaib SaleemMedicine, Mayo Hospital, Lahore 54000, Punjab, Pakistan.
Ahmed IssaMedicine, Medical University of the Americas, Nevis, West Indies.
Jain NiteshCritical Care Medicine, Mayo Clinic Health System, Mankato, MN 56001, United States.
Abbas B JamaCritical Care Medicine, Mayo Clinic Health System, Mankato, MN 56001, United States.
Anwar KhedrMedicine, BronxCare Health System, Bronx, NY 10457, United States.
Sydney BoikeMedicine, University of Minnesota Medical School, Minneapolis, MN 55455, United States.
Mikael MirMedicine, University of Minnesota Medical School, Minneapolis, MN 55455, United States.
Noura AttallahCritical Care Medicine, Mayo Clinic Health System, Mankato, MN 56001, United States.
Salim SuraniMedicine & Pharmacology, Texas A&M University Health Science Center, College Station, TX 77843, United States.
Syed A KhanCritical Care Medicine, Mayo Clinic Health System, Mankato, MN 56001, United States.
Mayo Clinic Health System · USUniversity of Minnesota Medical Center · USCatholic Medical Center · USMayo Clinic · USMayo Hospital · PKMontefiore Health System · USSt. Vincent's Medical Center · USUniversity of Sharjah · AEUniversity of the West Indies System · JM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemia state (HHS) are two life-threatening metabolic complications of diabetes that significantly increase mortality and morbidity. Despite major advances, reaching a uniform consensus regarding the diagnostic criteria and treatment of both conditions has been challenging. A significant overlap between these two extremes of the hyperglycemic crisis spectrum poses an additional hurdle. It has well been noted that a complete biochemical and clinical patient evaluation with timely diagnosis and treatment is vital for symptom resolution. Worldwide, there is a lack of large-scale studies that help define how hyperglycemic crises should be managed. This article will provide a comprehensive review of the pathophysiology, diagnosis, and management of DKA-HHS overlap.

Indexed as

DiabetesDiabetic ketoacidosisHypernatremiaHyperosmolar ComaHyperosmolar hyperglycemia stateMetabolic acidosis

Identifiers

PMID36405291
PMCPMC9669841
OpenAlexW4308017915

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.